2 completed, 1 withdrawn. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Phoenix Molecular Imaging: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression Sodium Acetate C11 PET/CT Imaging - Gliomas | Phase 2 / Phase 3 | Withdrawn | Phoenix Molecular Imaging | 2014-05-01 | 2016-09-28 | |
| C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma C11-Sodium Acetate - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Completed | Phoenix Molecular Imaging | 300 | 2012-04-01 | 2019-03-07 |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma Sodium Acetate C11 - Prostate Cancer | Phase 2 | Completed | Phoenix Molecular Imaging | 2000 | 2011-04-01 | 2019-03-07 |
Prostatic Neoplasms (2) · Glioblastoma (1) · Glioma (1) · Recurrence (1)
Carbon-11 (2) · carbon-11 acetate (2) · Magnetic Resonance Spectroscopy (1)
United States (3)
Fabio Almeida, MD (2) · Fabio Almeida, M.D. (1)